CHM and Macular dystrophy: As patients presenting with a clearly recognizable macular dystrophy phenotype (including those associated with variants in ABCA4, PRPH2, RS1, BEST1) and X‐linked rod‐cone dystrophy/Choroideremia (RPGR, RP2, CHM) were investigated by alternative pathways, the diagnostic yield of NGS176 for all patients with IRD is likely to be significantly higher than we report.